Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How much Koolaid did you have to drink to write that BS?
If the data didn’t suck it would’ve been on the market 5 years ago.
Diagnosed with brain cancer in 1998. Numerous treatments and surgeries until 2014 when she got DCVax.
All the other stuff worked for the first 16 years of her 25 year journey.
The whole story, not just the DCvax part.
Inovio is LPs inspiration. A 22 year old company that has zero approved products.
The initial installment is $150k. I’ve posted Advents patient form before. Maintenance doses are $25k twice a year. So you’ve probably got 2 new patients and 2 who have gotten their first booster after a year or 1 patients with 2 boosters.
It’s funny when you use their own favorite website braintumor.org to show how stupid and wrong they are.
What a tear. Almost back to where it was in July. I guess when one backs garbage, it doesn't take much to get excited.
Perhaps she can go by horse drawn carriage? And get as much accomplished as the 2016 SAB that this board hyped. Since apparently Zoom or Google meet, or a scanner or a translator isn't "a thing" at NWBO as proven by all the excuses during covid, the flu, vacation, and every other stupid thing coming from the NWBO PR department.
Nothing in a 10Q has ever moved the SP up. There's usually crap buried in there that corrects the shills lies.
Can you read?
Steady revenue stream for LP when she sells Advent. Cognate 2.0.
Not short, never been. Just want to watch this trainwreck end and the 15+ year money making scam of LP with it. And watch all the douchy shills go down too.
Perhaps NWBO is moving into the placebo mass production market making Direct with their million dollar Flaskworks?
Another patent nobody gives a shit about but this board. This board has hyped NWBO patents for 12 years and the stock is 95% off it's high with a bloated OS.
This statement only applies in the context of this board if your Ex is Linda Powers.
Maybe they will double revenue sequentially.
About what? Them ever submitting the trainwreck data? To the MHRA, because they don't have a definitive document explaining that an ECA needs to be created before a trial is run and include patient level data like the FDA does (hence no FDA submission).
It's in the footnotes of the same agreement for Cognate profits going to NWBO shareholders.
Yep you and every long never bought all those cheapies you harped about when this was $3-$12.
It is also common for tiny biotechs to fail their lone product clinical trial, admit it, and toil around in sub .10 land until they rot on a vine. Unless this, who keeps fleecing shareholders so LP can build out her 2nd CDMO.
And just like the idiots who say they haven't lost anything because they haven't sold you are not "up across the board" unless you've sold.
More like "in the future".
Is flipper really using a "bad math to count days of the year" excuse? You can literally Google "what date is xx days from
The company could ask Alexa this. But if they are doing the 1st grade math, and get this wrong, how the hell are they gonna submit anything to any agency for approval given all the actual "math" involved?
Congratulations, you now understand their need for silence
Excuses. It's what flipper is paid to do going on 10 years now. Not sure why they ever paid Les or Innes.
Just trust LP! Just like Woodford did with his $90+ million investment.
Somehow that "unintelligent management" has fleeced shareholders not once, but twice into building out CDMOs that LP will sell for hundreds of millions with no benefit to said shareholders while the share price crumbled over 90%, outstanding shares ballooned to over a billion, and still no submission.
but the results for the secondary main endpoint appear promising
That idiot doesn't know what an "endpoint" is.
You can't be serious. You spent a lot of posts trying to prove PFS was gonna be a winner.
This you?
Alphapuppy previous musings on primary PFS
My best-educated hypothesis is that clearly, the DCVax-L trial is going to return a positive result on the primary end point
The nice thing about this PFS review also is that there is no crossover effect between the curves such as could occur with my prior overall survival analysis OS.
The study’s primary endpoint is PFS, and the secondary endpoint is OS.
You'd be triggered too if you had your life savings tied up in a scam.
I've said this scam wouldn't be approved despite the company saying "soon" for the last 8 years. It hasn't been approved. They haven't even submitted anything.
Now go back and see all the idiots saying the SP would be at $100 over the last 8 years. All wrong. Those that said over $1? All wrong.
Anyone saying they haven't been fleeced by self serving LP? All wrong.
Of course you are not certain because you found no breadcrumbs indicating such. Honestly have you ever been right about anything in your 50k posts?
Remember his career is removing posts on a shitty stock webpage while battling his 80 IQ.
The same BS claim was made last Q and it ended up being like 6 patients.
Short memory on this board. Ridiculous claims of specials revenue have been going on and proven wrong for 3 years now.
Sure. Another “secret super duper trial” done by NWBO. Any equivalency trial, which NWBO has said is required, is a material event. Show me the SEC filing showing it’s been done.
Wall of bullshit text.
The FDA said if they aren’t going to run a proper p3 and try to morph the trainwreck P2 into a P3 to “save time and money” per liar LP they should include crossover. The FDA also requires a predefined ECA. Not one done after absolute failure proven by shitty data.
Then remove all the sick patients like they did in the P3 trial and you are up to 15% which is where the control arm would’ve landed since the treatment patients did worse than control.
You should invest in UCLA if you like a 40 patient P1 trial. Zero influence on this turd of a company.
“Grapefruit juice would be sour by now.”
And still work better than Direct.
Nobody on this board influences the share price one way or another. The shitty data does. That’s why the share price has plummeted since TLD. The slimy ass company execs have lost over 90% SP since they scammed their lone institutional investor ever.
None of them bought the "cheapies" from $4-$12 when Woodford was involved. Funny how buying all the gift shares only applies to when it was .14, and not all the times it was over a 10 bagger from the current share price when claims were it would hit $100/share.
What does Bard say about breadcrumbs leading to nothing?